Foretinib
Other name
-
International/Other brands
-
Groups
Investigational
Structure
Prescription products
| Name | Dosage | Strength | Route | Labeller |
|---|---|---|---|---|
| No data available. | ||||
Target
HGF, KDR
Description
Foretinib has been used in trials studying the treatment of Cancer, Breast Cancer, Carcinoma, Renal Cell, Recurrent Breast Cancer, and Neoplasms, Head and Neck, among others. Foretinib is an orally available small molecule compound designed to target multiple RTKs implicated in the development, progression and spread of cancer. It inhibits the activation of MET, RON, ERK and AKT, decreased proliferation and increased apoptosis.
Indications
-
Other indications
-
Mechaism of action
-
Absorption
-
Metabolism
-
Toxicity
-